Evidence map›Paper›PMID 38567664›Full record

ReviewMolecular oncology2024

The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumours.

Matthias Schneider, Anna-Laura Potthoff, Georg Karpel-Massler, Patrick Schuss, Markus D Siegelin, Klaus-Michael Debatin, Hugues Duffau, Hartmut Vatter, Ulrich Herrlinger, Mike-Andrew Westhoff

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Molecular oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07021339 (Randomized, Controlled Trial of Anterior Temporal Lobectomy Versus Gross Total Resection in Newly-diagnosed Temporal Glioblastoma), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07021339 phase3recruitingnot on this map

Randomized, Controlled Trial of Anterior Temporal Lobectomy Versus Gross Total Resection in Newly-diagnosed Temporal Glioblastoma (ATLAS/NOA-29)

TypeinterventionalSponsorUniversity Hospital, BonnRan2024 to 2031Enrolled178ConditionsNewly-diagnosed Glioblastoma, Temporal LobeArmsAnterior temporal lobectomy (ATL), Gross Total Resection (GTR)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Matthias SchneiderDepartment of Neurosurgery, University Hospital Bonn, Germany.ORCID 0000-0002-6025-7479
Anna-Laura PotthoffDepartment of Neurosurgery, University Hospital Bonn, Germany.ORCID 0000-0002-5710-6557
Georg Karpel-MasslerDepartment of Neurosurgery, University Medical Center Ulm, Germany.
Patrick SchussDepartment of Neurosurgery, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Germany.
Markus D SiegelinDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, USA.
Klaus-Michael DebatinDepartment of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
Hugues DuffauDepartment of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, France.
Hartmut VatterDepartment of Neurosurgery, University Hospital Bonn, Germany.
Ulrich HerrlingerBrain Tumour Translational Research Group, University Hospital Bonn, Germany.ORCID 0000-0002-4011-9327
Mike-Andrew WesthoffDepartment of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
University Hospital Bonn · DEUniversity Hospital Ulm · DEColumbia University Irving Medical Center · USInserm · FRUnfallkrankenhaus Berlin · DEUniversität Ulm · DE

Funding

German Cancer Aid 70113307German Cancer Aid 70114652German Ministry of Education and Research 01EN2008Mildred Scheel School of OncologyMinistry of Culture and Science of the State of Nordrhein-Westfalen NW21-062H
6 · The paper itself

Abstract

In recent years, the discovery of functional and communicative cellular tumour networks has led to a new understanding of malignant primary brain tumours. In this review, the authors shed light on the diverse nature of cell-to-cell connections in brain tumours and propose an innovative treatment approach to address the detrimental connectivity of these networks. The proposed therapeutic outlook revolves around three main strategies: (a) supramarginal resection removing a substantial portion of the communicating tumour cell front far beyond the gadolinium-enhancing tumour mass, (b) morphological isolation at the single cell level disrupting structural cell-to-cell contacts facilitated by elongated cellular membrane protrusions known as tumour microtubes (TMs), and (c) functional isolation at the single cell level blocking TM-mediated intercellular cytosolic exchange and inhibiting neuronal excitatory input into the malignant network. We draw an analogy between the proposed therapeutic outlook and the Alcatraz Federal Penitentiary, where inmates faced an impassable sea barrier and experienced both spatial and functional isolation within individual cells. Based on current translational efforts and ongoing clinical trials, we propose the Alcatraz-Strategy as a promising framework to tackle the harmful effects of cellular brain tumour networks.

Indexed as

Brain NeoplasmsAnimalsCell CommunicationHumansAlcatrazbrain tumorsgap junctionssupramarginal resectiontumour microtubestumour networks

Identifiers

PMID38567664
PMCPMC11619800
OpenAlexW4393851287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.